Jane Street’s Impact BioMedical IBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Buy
+1,944
New +$14.5K ﹤0.01% 11291
2026
Q1
– Sell
-1,116
Closed -$7.11K – 13309
2025
Q4
$7.11K Buy
+1,116
New +$7.45K ﹤0.01% 10883
2024
Q4
– Sell
-1,059
Closed -$26.7K – 10858
2024
Q3
$26.7K Buy
+1,059
New +$31.6K ﹤0.01% 9261

Other funds holding IBO

Jane Street's IBO Position: Q2 2026 in Review

Jane Street opened a new position in Impact BioMedical (IBO) in Q2 2026: 1,944 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #11291 among its holdings. This is a return to the name: Jane Street previously reported a position in IBO as recently as Q4 2025.

Jane Street first reported a position in IBO in Q3 2024 and has held it in 3 quarters since. The position peaked at $26.7K in Q3 2024. 20 funds tracked by Wall St. Rank hold IBO as of Q2 2026.

  • Jane Street held 1,944 shares of Impact BioMedical worth $11.3K as of Q2 2026.
  • Impact BioMedical was a new Jane Street position in Q2 2026.
  • Impact BioMedical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11291 holding.
  • Jane Street first reported a position in Impact BioMedical in Q3 2024 and has held it in 3 quarters since.
  • Jane Street's Impact BioMedical position peaked at $26.7K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.